Overview
Legal name
VALIRX PLC
Region
Unknown
Registered address
20 WENLOCK ROAD
LONDON
ENGLAND
N1 7GU
Insolvency history
No
Company
Active
PLC
Company profile
Valirx PLC
Accelerating Biomedical Innovation | Drug Development | ValiRx
ValiRx provides the scientific, financial and commercial framework to accelerate biomedical innovations for effective and efficient drug development
CRN
03916791
Founded
2000
Age
26
Corporate ownership
Updated 06 Jun 2026 16:52
Valirx PLC
No active corporate controller recorded.
Company events
Reference milestones and recent Companies House filing stream events.
8 events
15 Jan
2027
Confirmation statement due
Confirmation DueNext confirmation statement due date
30 Jun
2026
Accounts due
Accounts DueNext accounts due date
01 Jan
2026
Confirmation statement filed
ConfirmationLast confirmation statement made up date
31 Dec
2024
Accounts filed
AccountsLast accounts made up date
19 Oct
2024
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQ0MDIxNjAzM2FkaXF6a2N4
Published 19 Oct 2024 09:40
16 Aug
2024
Termination Director Company With Name Termination Date
OfficersTM01 | Transaction MzQzMjUxNjEzM2FkaXF6a2N4
Published 16 Aug 2024 15:49
12 Aug
2024
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzQzMTg1NzIwMGFkaXF6a2N4
Published 12 Aug 2024 13:39
26 Jan
2000
Incorporated
InceptionCompany registered at Companies House
Public funding
2 awards
First funded
2009
Funded years
2009, 2013
Age at first award
9 years
Projects
2013
EU-Funded
Lead participant
D-SIST
1 Jul 2013 to 30 Jun 2016
Awarded
£240,000
Total cost £1,203,137
Awaiting Public Project Summary
2009
EU-Funded
Lead participant
Geneice
1 Jun 2009 to 31 May 2012
Awarded
£237,500
Total cost £475,000
Awaiting Public Project Summary
Product types
EU-Funded